Clinical and neuropathological features of progressive supranuclear palsy in Leucine rich repeat kinase (LRRK2) G2019S mutation carriers

Mov Disord. 2018 Feb;33(2):335-338. doi: 10.1002/mds.27225. Epub 2017 Nov 9.

Dolores Vilas¹, Madeleine Sharp^{2

3}, Ellen Gelpi⁴, David Genís⁵, Karen S Marder^{2

3}, Etty Cortes⁶, Jean-Paul Vonsattel⁶, Eduard Tolosa^{1

7}, Roy N Alcalay^{2

3}

¹ Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, Universitat de Barcelona, Catalonia, Spain.
² Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
³ Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
⁴ Neurological Tissue Bank of the Biobanc-Hospital Clinic-IDIBAPS, Institut d'Investigacions Biomediques August Pi iSunyer, Barcelona, Spain.
⁵ Neurology Service, Hospital Universitari Dr. Josep Trueta, Hospital de Santa Caterina, Girona, Catalonia, Spain.
⁶ Department of Pathology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
⁷ Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Madrid, Spain.

No abstract available

Publication types